Health & Biotech
MGC Pharmaceuticals (ASX: MXC) has changed its name to Argent Biopharma - RGT (ASX: RGT).
Below are the previous articles from MGC Pharmaceuticals (ASX: MXC):
RELATED STOCKHEAD STORIES
Health & Biotech
Cash-flow surge: MGC Pharma boosts outlook as revenue accelerates in the June quarter
News
Weed Week: Illinois legalises recreational pot use… and now, the US Feds can’t interfere
Health & Biotech
MGC takes a Euro trip and hits Germany with a brand new dist deal
Health & Biotech
Health: Althea scores first UK customer, eyes off local processing facility
Health & Biotech
Pot stock MGC Pharma is racing into Brazil with new distribution deal
Health & Biotech
Weed Week: Here comes the latest hot take on legal dope from… the Country Women’s Association
Health & Biotech
Medicinal cannabis distributors are loving what MGC is selling
Health & Biotech
MGC Pharma pulls in over half a million in Q2 revenue
News
Weed Week: Which of you were forced to sell your beloved pot stocks last week?
News
Weed Week: Will Australia fear to tread where NZ steps with cannabis legalisation?
Health & Biotech
MGC births first cannabis products into the UK
Health & Biotech
Epilepsy and dementia sufferers across the globe to benefit from new MGC Pharma agreements
Health & Biotech
MGC Pharma jumps on the China export train, shares rise 38pc
Health & Biotech
The UK rolls out the welcome mat to MGC Pharma’s epilepsy treatment
Health & Biotech
Pure pharma: How MGC Pharma is setting up for 2019 and beyond
Health & Biotech
MGC Pharma adds expertise to its board as it progresses toward becoming a major cannabis biopharma
Health & Biotech